Ovarian cancer-targeted near-infrared fluorophores for fluorescence-guided surgery
- PMID: 37082670
- PMCID: PMC10113083
- DOI: 10.21037/atm-22-6455
Ovarian cancer-targeted near-infrared fluorophores for fluorescence-guided surgery
Keywords: Pafolacianine; fluorescence guided surgery; folate receptor; near-infrared imaging; ovarian cancer.
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-6455/coif). HSC is a co-founder of Nawoo Vision (stock ownership), and has no relevant financial or non-financial interests to disclose. The other author has no conflicts of interest to disclose.
Comment on
-
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).J Clin Oncol. 2023 Jan 10;41(2):276-284. doi: 10.1200/JCO.22.00291. Epub 2022 Sep 7. J Clin Oncol. 2023. PMID: 36070540 Free PMC article. Clinical Trial.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources